Business ExpansionNelson is opening a new sterility assurance clean room, marking a significant milestone that should enhance the product portfolio and improve capabilities for pharma customers.
Market PositionSHC is well positioned in the context of tariff-related uncertainty, given their service-based model in their Sterigenics and Nelson Labs businesses.
Regulatory ImpactNelson volumes are benefiting from new regulatory requirements across various end-markets, including bioprocessing and medtech.